Citigroup Inc Kymera Therapeutics, Inc. Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 19,586 shares of KYMR stock, worth $953,642. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,586

Previous 220,911 91.13%

Holding current value

$953,642

Previous $8.88 Million 93.42%

% of portfolio

0.0%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$29.85 - $39.42 $6.01 Million - $7.94 Million	-201,325 Reduced 91.13%	19,586 $584,000
Q1 2024 May 10, 2024	BUY	$22.9 - $43.57 $3.02 Million - $5.75 Million	131,982 Added 148.41%	220,911 $8.88 Million
Q4 2023 Feb 09, 2024	SELL	$10.97 - $26.84 $130,180 - $318,510	-11,867 Reduced 11.77%	88,929 $2.26 Million
Q3 2023 Nov 09, 2023	SELL	$13.9 - $23.88 $108,030 - $185,595	-7,772 Reduced 7.16%	100,796 $1.4 Million
Q2 2023 Aug 10, 2023	SELL	$22.4 - $34.92 $2.15 Million - $3.36 Million	-96,163 Reduced 46.97%	108,568 $2.5 Million
Q1 2023 May 11, 2023	BUY	$24.84 - $38.75 $1.8 Million - $2.82 Million	72,647 Added 55.0%	204,731 $6.07 Million
Q4 2022 Feb 09, 2023	SELL	$19.57 - $30.92 $1.35 Million - $2.13 Million	-68,956 Reduced 34.3%	132,084 $3.3 Million
Q3 2022 Nov 10, 2022	BUY	$20.91 - $34.27 $214,097 - $350,890	10,239 Added 5.37%	201,040 $4.38 Million
Q2 2022 Aug 10, 2022	BUY	$14.13 - $42.55 $2.39 Million - $7.19 Million	169,002 Added 775.27%	190,801 $3.76 Million
Q1 2022 May 12, 2022	SELL	$35.3 - $64.68 $2.11 Million - $3.87 Million	-59,852 Reduced 73.3%	21,799 $923,000
Q4 2021 Feb 10, 2022	BUY	$49.91 - $65.56 $1.41 Million - $1.86 Million	28,313 Added 53.08%	81,651 $5.18 Million
Q3 2021 Nov 10, 2021	BUY	$47.8 - $66.66 $2.55 Million - $3.56 Million	53,338 New	53,338 $3.13 Million

Others Institutions Holding KYMR

# of Institutions

160

Shares Held

63.1M

Call Options Held

22.6K

Put Options Held

14.4K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.66B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account